On Monday, Piper Sandler maintained its Overweight rating and $110.00 stock price target for Merit Medical Systems , Inc. (NASDAQ:MMSI), following the presentation of favorable clinical trial results.
Wells Fargo adjusted its outlook on Merit Medical Systems , Inc. (NASDAQ:MMSI) by increasing the price target to $103 from the previous $85, while maintaining an Equal Weight rating on the stock.
On Monday, Piper Sandler maintained its Overweight rating and $110.00 stock price target for Merit Medical Systems , Inc. (NASDAQ:MMSI), following the presentation of favorable clinical trial results.
She added that patients with serious conditions, such as those with kidney failure, rely on medical devices like oxygen machines or dialysis equipment. These patients must wait for lengthy ...
Scientists have discovered that a protein linked to prostate cancer is associated with more aggressive disease—it could be a new target for ... Honorary Consultant Medical Oncologist at The ...
Wells Fargo (NYSE:WFC) adjusted its outlook on Merit Medical Systems , Inc. (NASDAQ:MMSI) by increasing the price target to $103 from the previous $85, while maintaining an Equal Weight rating on the ...